Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Associations of healthy lifestyle with life expectancy and cancer free life expectancy Eleanor Watts National Cancer Institute PLCO Nov 21, 2022 PLCO-1100
Greenspace, noise pollution, and cancer risk in the PLCO cohort Rena Jones National Cancer Institute PLCO Nov 21, 2022 PLCO-1105
Mathematical modeling of biomarker dynamics in cancer patients Frederick Adler University of Utah PLCO Nov 14, 2022 PLCO-1099
Risk Factors of Prostate Cancer - A Statistical Analysis Francesco Patrucco Humanitas University PLCO Nov 9, 2022 PLCO-1098
Machine Learning Model to Predict Colorectal Cancer Bence Lukacsy Barrington High School PLCO Nov 9, 2022 PLCO-1097
Clarifying Lung Cancer Risk Among Breast Cancer Survivors Keith Sigel The Mount Sinai Hospital PLCO Nov 9, 2022 PLCO-1092
Effect of risk-stratified screening with flexible sigmoidoscopy on colorectal cancer incidence and mortality Yubei Huang Tianjin Medical University Cancer Institute and Hospital PLCO Nov 4, 2022 PLCO-1094
What does the National Lung Cancer Screening Trial imply for the effectiveness of computerized tomography screening in the US population? Issa Dahabreh Harvard University NLST Nov 2, 2022 NLST-983
Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates Hormuzd Katki NCI PLCO Nov 1, 2022 PLCO-1091
Association between Changes among Multiple Rounds Chest X-ray and Lung Cancer Risk in Two Screening Trials Ya Liu Tianjin Medical University Cancer Institute and Hospital NLST Nov 1, 2022 NLST-982
Progression and regression in chest X-ray with lung cancer incidence and mortality in Two Screening Trials Ya Liu Tianjin Medical University Cancer Institute and Hospital PLCO Nov 1, 2022 PLCO-1090
Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study Yunpeng Yu Indiana University PLCO Nov 1, 2022 PLCO-1088
Deep learning for indirect and direct cardiovascular risk estimation from ungated chest CT Piotr Slomka Cedars-Sinai NLST Nov 1, 2022 NLST-981
Colorectal cancer predicting model established on a large prospective screening project. Ziqi Zhang Sun Yat-Sen University Cancer Center PLCO Nov 1, 2022 PLCO-1087
ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING Kezban Alpan Middlesex University PLCO Nov 1, 2022 PLCO-1089
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco LSS Oct 27, 2022 LSS-3
Self-supervised learning for covid-19 diagnosis via Chest X-Rays Wenqiang LI The Hong Kong University of Science and Technology PLCO Oct 27, 2022 PLCOI-1085
Diabetes risk reduction diet and colorectal carcinogenesis: a prospective cohort study Chengcheng Liu The Second Affiliated Hospital, Zhejiang University School of Medicine PLCO Oct 27, 2022 PLCO-1082
Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop risk-adapted colonoscopy surveillance strategies Chengcheng Liu The Second Affiliated Hospital, Zhejiang University School of Medicine PLCO Oct 27, 2022 PLCO-1083
Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis Ben Armstrong Massachusetts Institute of Technology PLCO Oct 27, 2022 PLCO-1080